SMARCB1 and schwannoma: Mouse model of SMARCB1-related schwannomas). The fact that NF2 loss is important for the development of schwannomas is also reflected in the observation that at least 50–75% of sporadic schwannomas exhibit somatic pathogenic NF2 variants [380, 382, 383].